Jasmine Battle is a pharmacist who is specialized in Psychiatric in Charleston, South Carolina. Patients can reach her at 109 Bee St, Charleston or contact her on 843-577-5011. Active license number of Jasmine Battle is 60477 for Psychiatric in South Carolina. Jasmine Battle is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Jasmine Battle speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Jasmine Battle
Specialization:
Psychiatric
Credentials:
PHARMD
Gender:
Female
Location:
109 Bee St, Charleston, South Carolina, 29401-5703
Phone:
843-577-5011
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Jasmine Battle are as mentioned below.
NPI Number:
1689564056
NPI Enumeration Date:
08 Jul, 2025
NPI Last Update On:
08 Jul, 2025
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jasmine Battle are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
60477
South Carolina
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
109 Bee St, Charleston, South Carolina
Zip:
29401-5703
Phone Number:
--
Fax Number:
--
Patients can reach Jasmine Battle at 109 Bee St, Charleston, South Carolina or can call on phone at 843-577-5011.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.